Fish oil attenuates methylmalonate-induced seizures

Epilepsy Research

Volumn 105, Issue 1-2, 2013, Pages 69-76

  Banderó, Cristina Ruedell Reschke ^a   Salvadori, Mirian G S S ^a   Gomes, Anajara Teixeira ^a   Dal Ri, Nadja M K ^a   Furian, Ana Flávia ^a   Oliveira, Mauro Schneider ^a   Rambo, Leonardo Magno ^a   Scorza, Fulvio A ^b   Cysneiros, Roberta M ^c   Emanuelli, Tatiana ^a   Mello, Carlos Fernando ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c MACKENZIE PRESBYTERIAN UNIVERSITY   (Brazil)

Author keywords

Fatty acid; Fish oil; Methylmalonate; Oleic acid; Seizure

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CREMOPHOR; FISH OIL; METHYLMALONIC ACID; OLEIC ACID; PROEPA; PROSTAGLANDIN E2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; BRAIN SLICE; CELL VIABILITY; CONTROLLED STUDY; DIET SUPPLEMENTATION; ELECTROENCEPHALOGRAPHY; ENZYME ACTIVITY; FOOD INTAKE; HYDROLYSIS; LATENT PERIOD; LIPID COMPOSITION; MALE; MYOCLONUS; NONHUMAN; PARIETAL CORTEX; PRIORITY JOURNAL; RAT; TONIC CLONIC SEIZURE;

ANIMALS; ANTICONVULSANTS; ELECTROENCEPHALOGRAPHY; FISH OILS; MALE; METHYLMALONIC ACID; RANDOM ALLOCATION; RATS; RATS, WISTAR; SEIZURES;

EID: 84878447362     PISSN: 09201211     EISSN: 18726844     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2013.01.005     Document Type: Article

References (63)

1. Aldamiz-Echevarria L., Sanjurjo P., Elorz J., Prieto J.A., Perez C., Andrade F., Rodriguez-Soriano J. Effect of docosahexaenoic acid administration on plasma lipid profile and metabolic parameters of children with methylmalonic acidaemia. J. Inherit. Metab. Dis. 2006, 29:58-63.
2. Andre V., Marescaux C., Nehlig A., Fritschy J.M. Alterations of hippocampal GAbaergic system contribute to development of spontaneous recurrent seizures in the rat lithium-pilocarpine model of temporal lobe epilepsy. Hippocampus 2001, 11:452-468.
3. Bergström S., Blomstrand R., Borgström B. Route of absorption and distribution of oleic acid and triolein in the rat. Biochem. J. 1954, 58:600-604.
4. Bourre J.M., Dumont O., Piciotti M., Clement M., Chaudiere J., Bonneil M., Nalbone G., Lafont H., Pascal G., Durand G. Essentiality of omega 3 fatty acids for brain structure and function. World Rev. Nutr. Diet. 1991, 66:103-117.
5. Bromfield E., Dworetzky B., Hurwitz S., Eluri Z., Lane L., Replansky S., Mostofsky D. A randomized trial of polyunsaturated fatty acids for refractory epilepsy. Epilepsy Behav. 2008, 12:187-190.
6. Calder P.C. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am. J. Clin. Nutr. 2006, 83:1505S-1519S.
7. Caughey G.E., Mantzioris E., Gibson R.A., Cleland L.G., James M.J. The effect on human tumor necrosis factor alpha and interleukin 1 beta production of diets enriched in n-3 fatty acids from vegetable oil or fish oil. Am. J. Clin. Nutr. 1996, 63:116-122.
8. Chu A.J., Walton M.A., Prasad J.K., Seto A. Blockade by polyunsaturated n-3 fatty acids of endotoxin-induced monocytic tissue factor activation is mediated by the depressed receptor expression in THP-1 cells. J. Surg. Res. 1999, 87:217-224.
9. De Caterina R., Cybulsky M.I., Clinton S.K., Gimbrone M.A., Libby P. The omega-3 fatty acid docosahexaenoate reduces cytokine-induced expression of proatherogenic and proinflammatory proteins in human endothelial cells. Arterioscler. Thromb. 1994, 14:1829-1836.
10. de Mello C.F., Begnini J., Jiménez-Bernal R.E., Rubin M.A., de Bastiani J., da Costa E., Wajner M. Intrastriatal methylmalonic acid administration indudes rotational behavior and convulsions through glutamatergic mechanisms. Brain Res. 1996, 721(1/2):120-125.
11. Duda M.K., O'Shea K.M., Lei B., Barrows B.R., Azimzadeh A.M., McElfresh T.E., Hoit B.D., Kop W.J., Stanley W.C. Dietary supplementation with omega-3 PUFA increases adiponectin and attenuates ventricular remodeling and dysfunction with pressure overload. Cardiovasc. Res. 2007, 76:303-310.
12. Dutra J.C., Dutra-Filho C.S., Cardozo S.E., Wannmacher C.M., Sarkis J.J., Wajner M. Inhibition of succinate dehydrogenase and beta-hydroxybutyrate dehydrogenase activities by methylmalonate in brain and liver of developing rats. J. Inherit. Metab. Dis. 1993, 16(1):147-153.
13. Dyall S.C., Michael-Titus A.T. Neurological benefits of omega-3 fatty acids. Neuromolecular Med. 2008, 10:219-235.
14. Engstrom K., Wallin R., Saldeen T. Effect of low-dose aspirin in combination with stable fish oil on whole blood production of eicosanoids. Prostaglandins Leukot. Essent. Fatty Acids 2001, 64:291-297.
15. Fenton W.G., Rosenblatt D.S. Disorders of propionate and methylmalonate metabolism. The Metabolic and Molecular Bases of Inherited Disease 2001, 2165-2193. McGraw-Hill, Health Professions Division, New York. C. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (Eds.).
16. Ferrari D., Cysneiros R.M., Scorza C.A., Arida R.M., Cavalheiro E.A., de Almeida A.C., Scorza F.A. Neuroprotective activity of omega-3 fatty acids against epilepsy-induced hippocampal damage: Quantification with immunohistochemical for calcium-binding proteins. Epilepsy Behav. 2008, 13:36-42.
17. Fighera M.R., Queiroz C.M., Stracke M.P., Brauer M.C., Gonzalez-Rodriguez L.L., Frussa-Filho R., Wajner M., de Mello C.F. Ascorbic acid and alpha-tocopherol attenuate methylmalonic acid-induced convulsions. Neuroreport 1999, 10:2039-2043.
18. Fiske C.H., Subbarow Y. The colorimetric determination of phosphorus. J. Biol. Chem. 1925, 66:375-400.
19. Fleck J., Ribeiro C.P., Schneider M., Sinhorin V.D.G., Rubin M.A., Mello C.F. Intrastriatal malonate administration induces convulsive behavior in rats. J. Inherit. Metab. Dis. 2004, 27:211-219.
20. Furian A.F., Oliveira M.S., Royes L.F., Fiorenza N.G., Fighera M.R., Myskiw J.C., Weiblen R., Rubin M.A., Frussa-Filho F., Mello C.F. GM1 ganglioside induces vasodilatation and increases catalase content in the brain. Free Radic. Biol. Med. 2007, 43:924-932.
21. Furian A.F., Oliveira M.S., Magni D.V., Souza M.A., Bortoluzzi V.T., Bueno L.M., Royes L.F., Mello C.F. L-NAME prevents GM1 ganglioside-induced vasodilation in the rat brain. Neuroch. Int. 2008, 53:362-369.
22. +-ATPase isoenzymes of brain membranes in the adult rat. J. Nutr. Biochem. 1999, 10:230-236.
23. Hartman L., Lago R.C. Rapid preparation of fatty acid methyl esters from lipids. Lab. Pract. 1973, 22:475-476.
24. Harvey K.A., Walker C.L., Xu Z., Whitley P., Pavlina T.M., Hise M., Zaloga G.P., Siddiqui R.A. Oleic acid inhibits stearic acid-induced inhibition of cell growth and pro-inflammatory responses in human aortic endothelial cells. J. Lipid Res. 2010, 51:3470-3480.
25. Hidalgo M.A., Nahuelpan C., Manosalva C., Jara E., Carretta M.D., Coneieros I., Loaiza A., Chihuailaf R., Burgos A. Oleic acid induces intracellular calcium mobilization, MAPK phosphorylation, superoxide production and granule release in bovine neutrophils. Biochem. Biophys. Res. Commun. 2011, 409:280-286.
26. Jamme I., Petit E., Divoux D., Gerbi A., Maixent J.M., Nouvelot A. Modulation of mouse cerebral Na+,K(+)-ATPase activity by oxygen free radicals. Neuroreport 1995, 7:333-337.
27. Jurkat-Rott K., Freilinger T., Dreier J.P., Herzog J., Gobel H., Petzold G.C., Montagna P., Gasser T., Lehmann-Horn F., Dichgans M. Variability of familial hemiplegic migraine with novel A1A2 Na+/K+-ATPase variants. Neurology 2004, 62:1857-1861.
28. Khalfoun B., Thibault F., Watier H., Bardos P., Lebranchu Y. Docosahexaenoic and eicosapentaenoic acids inhibit in vitro human endothelial cell production of interleukin-6. Adv. Exp. Med. Biol. 1997, 400B:589-597.
29. Leaf A. The electrophysiologic basis for the antiarrhythmic and anticonvulsant effects of n-3 polyunsaturated fatty acids: heart and brain. Lipids 2001, 36(Suppl.):S107-S110.
30. Lee J.H., O'Keefe J.H., Lavie C.J., Harris W.S. Omega-3 fatty acids: cardiovascular benefits, sources and sustainability. Nat. Rev. Cardiol. 2009, 6:753-758.
31. Lee T.H., Hoover R.L., Williams J.D., Sperling R.I., Ravalese J., Spur B.W., Robinson D.R., Corey E.J., Lewis R.A., Austen K.F. Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N. Engl. J. Med. 1985, 312:1217-1224.
32. Lu Y., Hong S., Yang R., Uddin J., Gotlinger K.H., Petasis N.A., Serhan C.N. Identification of endogenous resolvin E1 and other lipid mediators derived from eicosapentaenoic acid via electrospray low-energy tandem mass spectrometry: spectra and fragmentation mechanisms. Rapid Commun. Mass Spectrom. 2007, 21:7-22.
33. 2+ and respiratory chain complex II inhibition. J. Neurochem. 2004, 90:1025-1035.
34. +-ATPase activity in the rat striatum and cerebral cortex. Epilepsia 2003, 44:761-767.
35. Marisco P.C., Ribeiro M.C., Bonini J.S., Lima T.T., Mann K.C., Brenner G.M., Dutra-Filho C.S., Mello C.F. Ammonia potentiates methylmalonic acid-induced convulsions and TBARS production. Exp. Neurol. 2003, 182:455-460.
36. Mori T.A., Beilin L.J. Omega-3 fatty acids and inflammation. Curr. Atheroscler. Rep. 2004, 6:461-467.
37. Musto A.E., Gjorstrup P., Bazan N.G. The omega-3 fatty acid-derived neuroprotectin D1 limitshippocampal hyperexcitability and seizure susceptibility in kindling epileptogenesis. Epilepsia 2011, 52:1601-1608.
38. Oh Y.T., Lee J.Y., Lee J., Kim H., Yoon K.S., Choe W., Kang I. Oleic acid reduces lipopolysaccharide-induced expression of iNOS and COX-2 in BV2 murine microglial cells: possible involvement of reactive oxygen species, p38 MAPK, and IKK/NF-kappaB signaling pathways. Neurosci. Lett. 2009, 462:93-97.
39. Oliveira M.S., Furian A.F., Rambo L.M., Ribeiro L.R., Royes L.F., Ferreira J., Calixto J.B., Mello C.F. Modulation of pentylenetetrazol-induced seizures by prostaglandin E2 receptors. Neuroscience 2008, 152:1110-1118.
40. +-ATPase activity in rat hippocampus: implications for neurological diseases. J. Neurochem. 2009, 109:416-426.
41. 2 pathway facilitates pentylenetetrazol-induced seizures. Epilepsy Res. 2008, 79:14-21.
42. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1986, Academic Press, Sydney/Orlando.
43. Ribeiro L.R., Fighera M.R., Oliveira M.S., Furian A.F., Rambo L.M., Ferreira A.P.O., Saraiva A.L.L., Souza M.A., Lima F.D., Magni D.V., Dezengrini R., Flores E.F., Butterfield A., Ferreira J., Santos A.R.S., Mello C.F., Royes L.F.F. Methylmalonate-induced seizures are attenuated in inducible nitric oxide synthase knockout mice. Int. J. Dev. Neurosci. 2009, 27:157-163.
44. Royes L.F.F., Fighera M.R., Furian A.F., Oliveira M.S., Myskiw J.C., Fiorenza N.G., Petry J.C., Coelho R.C., Mello C.F. Effectiveness of creatine monohydrate on seizures and oxidative damage induced by methylmalonate. Pharmacol. Biochem. Behav. 2006, 83:136-144.
45. Royes L.F., Fighera M.R., Furian A.F., Oliveira M.S., Fiorenza N.G., Petry J.C., Coelho R.C., Mello C.F. The role of nitric oxide on the convulsive behavior and oxidative stress induced by methylmalonate: an electroencephalographic and neurochemical study. Epilepsy Res. 2007, 73:228-237.
46. 2 potentiates methylmalonate-induced seizures. Epilepsia 2012, 53(1):189-198.
47. Schlanger S., Shinitzky M., Yam D. Diet enriched with omega-3 fatty acids alleviates convulsion symptoms in epilepsy patients. Epilepsia 2002, 43:103-104.
48. + channels in rat olfactory receptor neurons. Eur. J. Neurosci. 2002, 16:2085-2094.
49. Taha A.Y., Burnham W.M., Auvin S. Polyunsaturated fatty acids and epilepsy. Epilepsia 2010, 51(8):1348-1355.
50. Toyoshima S., Watanable F., Saido H., Miyatake K., Nakano Y. Methylmalonic acid inhibits respiration in rat liver mitochondria. J. Nutr. 1995, 125:2846-2850.
51. 2 production and T cell function after fish-oil supplementation: response to antioxidant cosupplementation. Am. J. Clin. Nutr. 2003, 78:376-382.
52. Vezzani A. Inflammation and epilepsy. Epilepsy Curr. 2005, 5:1-6.
53. Vezzani A., French J., Bartfai T., Baram T.Z. The role of inflammation in epilepsy. Nat. Rev Neurol. 2011, 7:31-40.
54. von Schacky C., Kiefl R., Jendraschak E., Kaminski W.E. n-3 fatty acids and cysteinyl-leukotriene formation in humans in vitro, ex vivo, and in vivo. J. Lab. Clin. Med. 1993, 121(2):302-309.
55. von Schacky C., Harris W.S. Cardiovascular benefits of omega-3 fatty acids. Cardiovasc. Res. 2007, 73:310-315.
56. Vreugdenhil M., Bruehl C., Voskuyl R.A., Kang J.X., Leaf A., Wadman W.J. Polyunsaturated fatty acids modulate sodium and calcium currents in CA1 neurons. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:12559-12563.
57. Willis S., Samala R., Rosenberger T.A., Borges K. Eicosapentaenoic and docosahexaenoic acids are not anticonvulsant or neuroprotective in acute mouse seizure models. Epilepsia 2009, 50:138-142.
58. +-ATPase activity in cerebral cortex of rats. Neuroreport 2000, 11:2331-2334.
59. 2+ currents by polyunsaturated fatty acids in adult and neonatal rat ventricular myocytes. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:4182-4187.
60. + channels of neonatal rat ventricular myocytes. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:11000-11004.
61. Yehuda S., Rabinovitz S., Mostofsky D.I. Essential fatty acids are mediators of brain biochemistry and cognitive functions. J. Neurosci. Res. 1999, 56:565-570.
62. Young C., Gean P.W., Chiou L.C., Shen Y.Z. Docosahexaenoic acid inhibits synaptic transmission and epileptiform activity in the rat hippocampus. Synapse 2000, 37:90-94.
63. Yuen A.W., Sander J.W., Fluegel D., Patsalos P.N., Bell G.S., Johnson T., Koepp M.J. Omega-3 fatty acid supplementation in patients with chronic epilepsy: a randomized trial. Epilepsy Behav. 2005, 7:253-258.